{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T02:46:52Z","timestamp":1791341212571,"version":"4.3.1"},"reference-count":77,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2015,9,11]],"date-time":"2015-09-11T00:00:00Z","timestamp":1441929600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0136878","type":"journal-article","created":{"date-parts":[[2015,9,11]],"date-time":"2015-09-11T17:59:46Z","timestamp":1441994386000},"page":"e0136878","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":34,"title":["G2\/M Cell Cycle Arrest and Tumor Selective Apoptosis of Acute Leukemia Cells by a Promising Benzophenone Thiosemicarbazone Compound"],"prefix":"10.1371","volume":"10","author":[{"given":"Maia","family":"Cabrera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Gomez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Remes Lenicov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emiliana","family":"Echeverr\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carina","family":"Shayo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albertina","family":"Moglioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Davio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,9,11]]},"reference":[{"issue":"1","key":"ref1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1182\/blood.V62.1.1.1","article-title":"Stem cells in normal and leukemic hemopoiesis (Henry Stratton Lecture, 1982)","volume":"62","author":"EA McCulloch","year":"1983","journal-title":"Blood"},{"issue":"7","key":"ref2","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/nm0797-730","article-title":"Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell","volume":"3","author":"D Bonnet","year":"1997","journal-title":"Nature medicine"},{"issue":"13","key":"ref3","doi-asserted-by":"crossref","first-page":"3541","DOI":"10.1182\/blood.V98.13.3541","article-title":"Receptor- and mitochondrial-mediated apoptosis in acute leukemia: a translational view","volume":"98","author":"A Schimmer","year":"2001","journal-title":"Blood"},{"issue":"3","key":"ref4","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1182\/blood-2009-07-235358","article-title":"Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet","volume":"115","author":"H D\u00f6hner","year":"2010","journal-title":"Blood"},{"issue":"4","key":"ref5","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1182\/blood-2005-01-0178","article-title":"Drug therapy for acute myeloid leukemia","volume":"106","author":"M Tallman","year":"2005","journal-title":"Blood"},{"issue":"6","key":"ref6","doi-asserted-by":"crossref","first-page":"406","DOI":"10.2165\/00002018-199615060-00005","article-title":"A Risk-Benefit Assessment of Anthracycline Antibiotics in Antineoplastic Therapy","volume":"15","author":"R Abraham","year":"1996","journal-title":"Drug-Safety"},{"issue":"7","key":"ref7","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1038\/sj.leu.2401803","article-title":"Study of apoptosis-related responses of leukemic blast cells to in vitro anthracycline treatment","volume":"14","author":"MA Belaud-Rotureau","year":"2000","journal-title":"Leukemia"},{"issue":"11","key":"ref8","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1038\/sj.leu.2403144","article-title":"Apoptosis induction in peripheral leukemia cells by remission induction treatment in vivo: selective depletion and apoptosis in a CD34+ subpopulation of leukemia cells","volume":"17","author":"K Stahnke","year":"2003","journal-title":"Leukemia"},{"issue":"6","key":"ref9","doi-asserted-by":"crossref","first-page":"4025","DOI":"10.1074\/jbc.C400545200","article-title":"The Mitotic Spindle Checkpoint Is a Critical Determinant for Topoisomerase-based Chemotherapy","volume":"280","author":"C Vogel","year":"2005","journal-title":"Journal of Biological Chemistry"},{"issue":"1","key":"ref10","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/BF02932132","article-title":"Antimicrobial activity of a series of thiosemicarbazones and their Zn(II) and Pd(II) complexes","volume":"52","author":"I Kizilcikli","year":"2007","journal-title":"Folia microbiologica"},{"issue":"7","key":"ref11","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1016\/j.ejmech.2007.09.016","article-title":"Organotin(IV) complexes of 2-pyridineformamide-derived thiosemicarbazones: antimicrobial and cytotoxic effects","volume":"43","author":"I Mendes","year":"2008","journal-title":"European journal of medicinal chemistry"},{"issue":"17","key":"ref12","doi-asserted-by":"crossref","first-page":"4679","DOI":"10.1016\/j.bmc.2004.06.036","article-title":"Synthesis, characterization and in vitro anti-amoebic activity of new palladium(II) complexes with 5-nitrothiophene-2-carboxaldehyde N(4)-substituted thiosemicarbazones","volume":"12","author":"N Bharti","year":"2004","journal-title":"Bioorganic & medicinal chemistry"},{"issue":"18","key":"ref13","doi-asserted-by":"crossref","first-page":"4885","DOI":"10.1016\/j.bmc.2004.07.003","article-title":"In vitro activity and mechanism of action against the protozoan parasite Trypanosoma cruzi of 5-nitrofuryl containing thiosemicarbazones","volume":"12","author":"G Aguirre","year":"2004","journal-title":"Bioorganic & medicinal chemistry"},{"issue":"8","key":"ref14","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1016\/j.ejmech.2007.10.023","article-title":"New 1-indanone thiosemicarbazone derivatives active against BVDV","volume":"43","author":"L Finkielsztein","year":"2008","journal-title":"European journal of medicinal chemistry"},{"issue":"5","key":"ref15","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1093\/oxfordjournals.aje.a121340","article-title":"Field trials of methisazone as a prophylactic agent against smallpox","volume":"94","author":"G Heiner","year":"1971","journal-title":"American journal of epidemiology"},{"issue":"2","key":"ref16","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1093\/oxfordjournals.aje.a121057","article-title":"Prophylaxis of smallpox with methisazone","volume":"90","author":"D Bauer","year":"1969","journal-title":"American journal of epidemiology"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.steroids.2014.05.026","article-title":"Synthesis and antiproliferative activity of some steroidal thiosemicarbazones, semicarbazones and hydrozones","volume":"87","author":"C Gan","year":"2014","journal-title":"Steroids"},{"issue":"5","key":"ref18","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.jinorgbio.2008.12.016","article-title":"Synthesis, characterization and deepening in the comprehension of the biological action mechanisms of a new nickel complex with antiproliferative activity","volume":"103","author":"A Buschini","year":"2009","journal-title":"Journal of inorganic biochemistry"},{"issue":"3","key":"ref19","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1007\/s00280-011-1779-5","article-title":"A phase I and pharmacokinetic study of oral 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, NSC #663249) in the treatment of advanced-stage solid cancers: a California Cancer Consortium Study","volume":"69","author":"J Chao","year":"2012","journal-title":"Cancer chemotherapy and pharmacology"},{"issue":"1","key":"ref20","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ygyno.2013.04.019","article-title":"Radiochemotherapy plus 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, NSC #663249) in advanced-stage cervical and vaginal cancers","volume":"130","author":"C Kunos","year":"2013","journal-title":"Gynecologic oncology"},{"issue":"4","key":"ref21","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1158\/1078-0432.CCR-09-2469","article-title":"Phase I trial of pelvic radiation, weekly cisplatin, and 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, NSC #663249) for locally advanced cervical cancer","volume":"16","author":"C Kunos","year":"2010","journal-title":"Clinical cancer research: an official journal of the American Association for Cancer Research"},{"issue":"3","key":"ref22","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s10637-012-9863-1","article-title":"A phase I study of prolonged infusion of triapine in combination with fixed dose rate gemcitabine in patients with advanced solid tumors","volume":"31","author":"A Mortazavi","year":"2013","journal-title":"Investigational new drugs"},{"issue":"10","key":"ref23","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1038\/aps.2014.71","article-title":"Characterization of the anticancer effects of S115, a novel heteroaromatic thiosemicarbazone compound, in vitro and in vivo","volume":"35","author":"M-Y Liu","year":"2014","journal-title":"Acta pharmacologica Sinica"},{"issue":"7","key":"ref24","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1021\/jm101532u","article-title":"Role of metalation in the topoisomerase II\u03b1 inhibition and antiproliferation activity of a series of \u03b1-heterocyclic-N4-substituted thiosemicarbazones and their Cu(II) complexes","volume":"54","author":"B Zeglis","year":"2011","journal-title":"Journal of medicinal chemistry"},{"issue":"5","key":"ref25","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1021\/jm801585u","article-title":"2-Acetylpyridine thiosemicarbazones are potent iron chelators and antiproliferative agents: redox activity, iron complexation and characterization of their antitumor activity","volume":"52","author":"D Richardson","year":"2009","journal-title":"Journal of medicinal chemistry"},{"issue":"11","key":"ref26","doi-asserted-by":"crossref","first-page":"3322","DOI":"10.1021\/jm0512241","article-title":"Novel antitrypanosomal agents based on palladium nitrofurylthiosemicarbazone complexes: DNA and redox metabolism as potential therapeutic targets","volume":"49","author":"L Otero","year":"2006","journal-title":"Journal of medicinal chemistry"},{"issue":"1","key":"ref27","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2174\/1389557043487484","article-title":"The wide pharmacological versatility of semicarbazones, thiosemicarba-zones and their metal complexes","volume":"4","author":"H Beraldo","year":"2004","journal-title":"Mini reviews in medicinal chemistry"},{"issue":"6","key":"ref28","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.4155\/fmc.09.80","article-title":"Thiosemicarbazones: the new wave in cancer treatment","volume":"1","author":"D Kalinowski","year":"2009","journal-title":"Future medicinal chemistry"},{"issue":"5","key":"ref29","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1182\/blood-2004-03-0868","article-title":"Novel di-2-pyridyl-derived iron chelators with marked and selective antitumor activity: in vitro and in vivo assessment","volume":"104","author":"J Yuan","year":"2004","journal-title":"Blood"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"627","DOI":"10.3998\/ark.5550190.0001.413","article-title":"Synthesis and characterization of 2, 2-disubstituted thiadiazolines","volume":"4","author":"M Alho","year":"2000","journal-title":"Arkivoc"},{"issue":"28","key":"ref31","doi-asserted-by":"crossref","first-page":"21661","DOI":"10.1074\/jbc.M906893199","article-title":"Phosphorylation of Bcl-2 protein by CDC2 kinase during G2\/M phases and its role in cell cycle regulation","volume":"275","author":"Y Furukawa","year":"2000","journal-title":"The Journal of biological chemistry"},{"issue":"12","key":"ref32","doi-asserted-by":"crossref","first-page":"8469","DOI":"10.1128\/MCB.19.12.8469","article-title":"BCL-2 is phosphorylated and inactivated by an ASK1\/Jun N-terminal protein kinase pathway normally activated at G(2)\/M","volume":"19","author":"K Yamamoto","year":"1999","journal-title":"Mol Cell Biol"},{"issue":"1","key":"ref33","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1742-4658.2009.07366.x","article-title":"ERK and cell death: mechanisms of ERK-induced cell death\u2014apoptosis, autophagy and senescence","volume":"277","author":"S Cagnol","year":"2010","journal-title":"The FEBS journal"},{"issue":"5","key":"ref34","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1093\/carcin\/bgh052","article-title":"The role of activated MEK-ERK pathway in quercetin-induced growth inhibition and apoptosis in A549 lung cancer cells","volume":"25","author":"TT Nguyen","year":"2004","journal-title":"Carcinogenesis"},{"key":"ref35","first-page":"1","article-title":"Effect of estradiol and clomiphene citrate on Erk activation in breast cancer cells","author":"J Elloumi-Mseddi","year":"2014","journal-title":"Journal of receptor and signal transduction research"},{"issue":"2","key":"ref36","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/sj.onc.1204062","article-title":"Taxol-induced apoptosis depends on MAP kinase pathways (ERK and p38) and is independent of p53","volume":"20","author":"S Bacus","year":"2001","journal-title":"Oncogene"},{"issue":"50","key":"ref37","doi-asserted-by":"crossref","first-page":"39435","DOI":"10.1074\/jbc.M004583200","article-title":"Requirement for ERK activation in cisplatin-induced apoptosis","volume":"275","author":"X Wang","year":"2000","journal-title":"The Journal of biological chemistry"},{"issue":"6","key":"ref38","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.3892\/ijo.2012.1640","article-title":"ERK-modulated intrinsic signaling and G(2)\/M phase arrest contribute to the induction of apoptotic death by allyl isothiocyanate in MDA-MB-468 human breast adenocarcinoma cells","volume":"41","author":"S-C Tsai","year":"2012","journal-title":"International journal of oncology"},{"issue":"13","key":"ref39","doi-asserted-by":"crossref","first-page":"4459","DOI":"10.1073\/pnas.0306069101","article-title":"Complete loss of the tumor suppressor MAD2 causes premature cyclin B degradation and mitotic failure in human somatic cells","volume":"101","author":"L Michel","year":"2004","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/j.1749-6632.2009.04912.x","article-title":"Molecular response of HL-60 cells to mitotic inhibitors vincristine and taxol visualized with apoptosis-related gene expressions, including the new member BCL2L12","volume":"1171","author":"H Thomadaki","year":"2009","journal-title":"Annals of the New York Academy of Sciences"},{"issue":"5","key":"ref41","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1091\/mbc.E06-12-1092","article-title":"Specialized Roles of the Two Mitotic Cyclins in Somatic Cells: Cyclin A as an Activator of M Phase\u2013promoting Factor","volume":"18","author":"TK Fung","year":"2007","journal-title":"Molecular Biology of the Cell"},{"issue":"3","key":"ref42","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.semcdb.2005.02.014","article-title":"A roller coaster ride with the mitotic cyclins","volume":"16","author":"TK Fung","year":"2005","journal-title":"Seminars in cell & developmental biology"},{"issue":"11","key":"ref43","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1002\/1097-0142(20000601)88:11<2619::AID-CNCR26>3.0.CO;2-J","article-title":"Paclitaxel-induced cell death: where the cell cycle and apoptosis come together","volume":"88","author":"T Wang","year":"2000","journal-title":"Cancer"},{"issue":"6518","key":"ref44","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/374131a0","article-title":"Principles of CDK regulation","volume":"374","author":"D Morgan","year":"1995","journal-title":"Nature"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/S1097-2765(02)00540-3","article-title":"The anaphase-promoting complex: proteolysis in mitosis and beyond","volume":"9","author":"JM Peters","year":"2002","journal-title":"Mol Cell"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/nrm929","article-title":"The spindle checkpoint: structural insights into dynamic signalling","volume":"3","author":"A Musacchio","year":"2002","journal-title":"Nature Rev Mol Cell Biol"},{"issue":"4","key":"ref47","first-page":"1","article-title":"Anthracyclines in the Treatment of Cancer","volume":"54","author":"GN Hortob\u00e1gyi","year":"1997","journal-title":"Drugs"},{"issue":"12","key":"ref48","doi-asserted-by":"crossref","first-page":"R467","DOI":"10.1016\/S0960-9822(01)00283-4","article-title":"Cell cycle: How, when and why cells get rid of cyclin A","volume":"11","author":"T Tin Su","year":"2001","journal-title":"Current Biology"},{"issue":"1","key":"ref49","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1083\/jcb.153.1.121","article-title":"Cyclin A is destroyed in prometaphase and can delay chromosome alignment and anaphase","volume":"153","author":"N den Elzen","year":"2001","journal-title":"The Journal of cell biology"},{"issue":"6","key":"ref50","doi-asserted-by":"crossref","first-page":"3457","DOI":"10.1074\/jbc.M113.514430","article-title":"APOLLON protein promotes early mitotic CYCLIN A degradation independent of the spindle assembly checkpoint","volume":"289","author":"R Kikuchi","year":"2014","journal-title":"J Biol Chem"},{"issue":"1","key":"ref51","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ccr.2005.06.011","article-title":"Decoding the links between mitosis, cancer, and chemotherapy: The mitotic checkpoint, adaptation, and cell death","volume":"8","author":"BAA Weaver","journal-title":"Cancer Cell"},{"issue":"2","key":"ref52","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1124\/mi.11.2.12","article-title":"Spindle poisons and cell fate: a tale of two pathways","volume":"11","author":"DR Matson","year":"2011","journal-title":"Molecular interventions"},{"issue":"12","key":"ref53","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1172\/JCI9054","article-title":"Anticancer drug targets: cell cycle and checkpoint control","volume":"104","author":"GI Shapiro","year":"1999","journal-title":"Journal of Clinical Investigation"},{"issue":"6","key":"ref54","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1111\/j.1476-5381.2010.01127.x","article-title":"Principles of early drug discovery","volume":"162","author":"JP Hughes","year":"2011","journal-title":"British journal of pharmacology"},{"issue":"6","key":"ref55","doi-asserted-by":"crossref","first-page":"707","DOI":"10.3109\/02841869109092444","article-title":"Muscle cramps associated with vincristine therapy","volume":"30","author":"N Haim","year":"1991","journal-title":"Acta oncologica (Stockholm, Sweden)"},{"issue":"10","key":"ref56","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1002\/1097-0142(19940515)73:10<2515::AID-CNCR2820731011>3.0.CO;2-G","article-title":"Full dose vincristine (without 2-mg dose limit) in the treatment of lymphomas","volume":"73","author":"N Haim","year":"1994","journal-title":"Cancer"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"e411","DOI":"10.1038\/cddis.2012.148","article-title":"Mitosis-targeted anti-cancer therapies: where they stand","volume":"3","author":"KS Chan","year":"2012","journal-title":"Cell Death Dis"},{"issue":"20","key":"ref58","doi-asserted-by":"crossref","first-page":"7031","DOI":"10.1158\/1078-0432.CCR-04-0361","article-title":"Targeting mammalian target of rapamycin synergistically enhances chemotherapy-induced cytotoxicity in breast cancer cells","volume":"10","author":"WH Mondesire","year":"2004","journal-title":"Clin Cancer Res"},{"issue":"6","key":"ref59","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.ceb.2013.07.003","article-title":"Mitosis and apoptosis: how is the balance set?","volume":"25","author":"CH Topham","year":"2013","journal-title":"Current opinion in cell biology"},{"issue":"3","key":"ref60","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.molcel.2010.01.025","article-title":"The BCL-2 family reunion","volume":"37","author":"JE Chipuk","year":"2010","journal-title":"Molecular cell"},{"key":"ref61","article-title":"Phosphorylation of Bcl-2 Is a Marker of M Phase Events and Not a Determinant of Apoptosis","volume":"273","author":"YH Ling","year":"1998","journal-title":"Journal of Biological Chemistry"},{"issue":"3","key":"ref62","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1128\/MCB.00882-09","article-title":"Cyclin-dependent kinase 1-mediated Bcl-xL\/Bcl-2 phosphorylation acts as a functional link coupling mitotic arrest and apoptosis","volume":"30","author":"D Terrano","year":"2010","journal-title":"Molecular and cellular biology"},{"issue":"12","key":"ref63","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1038\/sj.leu.2401218","article-title":"Temporal relationship of CDK1 activation and mitotic arrest to cytosolic accumulation of cytochrome C and caspase-3 activity during Taxol-induced apoptosis of human AML HL-60 cells","volume":"12","author":"AM Ibrado","year":"1998","journal-title":"Leukemia"},{"issue":"6","key":"ref64","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/sj.neo.7900213","article-title":"Microtubule-targeting drugs induce bcl-2 phosphorylation and association with Pin1","volume":"3","author":"N Pathan","year":"2001","journal-title":"Neoplasia (New York, NY)"},{"issue":"2","key":"ref65","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.bmcl.2011.12.023","article-title":"Induction of microtubule-damage, mitotic arrest, Bcl-2 phosphorylation, Bak activation, and mitochondria-dependent caspase cascade is involved in human Jurkat T-cell apoptosis by aruncin B from Aruncus dioicus var. kamtschaticus","volume":"22","author":"C Han","year":"2012","journal-title":"Bioorganic & medicinal chemistry letters"},{"issue":"14","key":"ref66","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.1016\/j.febslet.2005.04.067","article-title":"Phosphorylation of BAD at Ser-128 during mitosis and paclitaxel-induced apoptosis","volume":"579","author":"M Berndtsson","year":"2005","journal-title":"FEBS letters"},{"issue":"8","key":"ref67","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1089\/ars.2012.4877","article-title":"Iron chelators with topoisomerase-inhibitory activity and their anticancer applications","volume":"18","author":"V Rao","year":"2013","journal-title":"Antioxidants & redox signaling"},{"issue":"3","key":"ref68","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1158\/1535-7163.MCT-05-0384","article-title":"A Ferrous-Triapine complex mediates formation of reactive oxygen species that inactivate human ribonucleotide reductase","volume":"5","author":"J Shao","year":"2006","journal-title":"Molecular cancer therapeutics"},{"issue":"8","key":"ref69","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.1021\/jm9014394","article-title":"A series of alpha-heterocyclic carboxaldehyde thiosemicarbazones inhibit topoisomerase IIalpha catalytic activity","volume":"53","author":"H Huang","year":"2010","journal-title":"Journal of medicinal chemistry"},{"issue":"15","key":"ref70","doi-asserted-by":"crossref","first-page":"3716","DOI":"10.1021\/jm070445z","article-title":"Design, synthesis, and characterization of novel iron chelators: structure-activity relationships of the 2-benzoylpyridine thiosemicarbazone series and their 3-nitrobenzoyl analogues as potent antitumor agents","volume":"50","author":"D Kalinowski","year":"2007","journal-title":"Journal of medicinal chemistry"},{"key":"ref71","article-title":"Thiosemicarbazone metal complexes: from structure to activity","author":"G Pelosi","year":"2010","journal-title":"Open Crystallography Journal"},{"issue":"4","key":"ref72","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1124\/pr.57.4.2","article-title":"The evolution of iron chelators for the treatment of iron overload disease and cancer","volume":"57","author":"D Kalinowski","year":"2005","journal-title":"Pharmacological reviews"},{"issue":"17","key":"ref73","doi-asserted-by":"crossref","first-page":"5271","DOI":"10.1021\/jm900552r","article-title":"Thiosemicarbazones from the old to new: iron chelators that are more than just ribonucleotide reductase inhibitors","volume":"52","author":"Y Yu","year":"2009","journal-title":"J Med Chem"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.ejmech.2012.10.039","article-title":"Initial evaluation of the antitumour activity of KGP94, a functionalized benzophenone thiosemicarbazone inhibitor of cathepsin L","volume":"58","author":"G Chavarria","year":"2012","journal-title":"European journal of medicinal chemistry"},{"issue":"4","key":"ref75","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/j.bmcl.2009.12.090","article-title":"Design, synthesis, and biological evaluation of potent thiosemicarbazone based cathepsin L inhibitors","volume":"20","author":"Kumar GD Kishore","year":"2010","journal-title":"Bioorg Med Chem Lett"},{"issue":"22","key":"ref76","doi-asserted-by":"crossref","first-page":"6610","DOI":"10.1016\/j.bmcl.2010.09.026","article-title":"Functionalized benzophenone, thiophene, pyridine, and fluorene thiosemicarbazone derivatives as inhibitors of cathepsin L","volume":"20","author":"GD Kumar","year":"2010","journal-title":"Bioorg Med Chem Lett"},{"issue":"Suppl 8","key":"ref77","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1186\/1471-2164-14-S8-S10","article-title":"Mechanistic insights into mode of action of novel natural cathepsin L inhibitors","volume":"14","author":"C Tyagi","year":"2013","journal-title":"BMC genomics"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0136878","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,21]],"date-time":"2022-05-21T18:08:29Z","timestamp":1653156509000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0136878"}},"subtitle":[],"editor":[{"given":"Ming-Hsien","family":"Chien","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,9,11]]},"references-count":77,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2015,9,11]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0136878","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,11]]}}}